Cargando…

Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review

Cold colorectal tumors are not likely to trigger a robust immune response and tend to suppress the immune response. There may be three reasons. First, the complex tumor microenvironment of cold colorectal cancer (CRC) leads to tolerance and clearance of immunotherapy. Second, the modification and co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Shi-Xun, Li, Li, Cai, Hui, Guo, Tian-Kang, Zhang, Lei-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993140/ https://www.ncbi.nlm.nih.gov/pubmed/36908678 http://dx.doi.org/10.5306/wjco.v14.i2.81

Ejemplares similares

Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches
por: Tintelnot, Joseph, et al.
Publicado: (2019)

Challenges and exploration for immunotherapies targeting cold colorectal cancer
por: Li, Dan-Dan, et al.
Publicado: (2023)

Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
por: Gilbert, D C, et al.
Publicado: (2012)

Implication of gut microbiome in immunotherapy for colorectal cancer
por: Koustas, Evangelos, et al.
Publicado: (2022)

Combined targeted therapy and immunotherapy for cancer treatment
por: Guo, Cheng-Xiang, et al.
Publicado: (2021)

Targeting cytotoxic T lymphocytes for cancer immunotherapy
por: Maher, J, et al.
Publicado: (2004)

Targets of immunotherapy for hepatocellular carcinoma: An update
por: Rai, Vikrant, et al.
Publicado: (2022)

Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential
por: Huang, Fang, et al.
Publicado: (2022)

Clinical challenges of glycemic control in the intensive care unit: A narrative review
por: Sreedharan, Roshni, et al.
Publicado: (2022)

Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
por: Cassese, Gianluca, et al.
Publicado: (2022)

Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1
por: Sun, Ke-Ran, et al.
Publicado: (2021)

Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
por: Contratto, Merly, et al.
Publicado: (2018)

The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
por: Sheng, Q, et al.
Publicado: (2011)

Sugar intake from sweetened beverages and diabetes: A narrative review
por: Tseng, Tung-Sung, et al.
Publicado: (2021)

The diversity of endothelial cells: a challenge for therapeutic angiogenesis
por: Conway, Edward M, et al.
Publicado: (2004)

Role of liver transplantation in the management of colorectal liver metastases: Challenges and opportunities
por: Tasoudis, Panagiotis T, et al.
Publicado: (2021)

Targeting telomerase for cancer therapeutics
por: Shay, J W, et al.
Publicado: (2008)

Progress in immunotherapy for small cell lung cancer
por: Zhao, Dong, et al.
Publicado: (2020)

Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions
por: Bo, Xiao-Wan, et al.
Publicado: (2021)

Current and emerging therapeutic strategies in pancreatic cancer: Challenges and opportunities
por: Manrai, Manish, et al.
Publicado: (2021)

RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
por: Chen, Shao-Long, et al.
Publicado: (2021)

Golgi Stress Response: New Insights into the Pathogenesis and Therapeutic Targets of Human Diseases
por: Kim, Won Kyu, et al.
Publicado: (2023)

Single nucleotide variations in the development of diabetic foot ulcer: A narrative review
por: Hu, Yan-Jun, et al.
Publicado: (2022)

Cancer heterogeneity: implications for targeted therapeutics
por: Fisher, R, et al.
Publicado: (2013)

Eph receptors as therapeutic targets in glioblastoma
por: Day, B W, et al.
Publicado: (2014)

Cold Tumors: A Therapeutic Challenge for Immunotherapy
por: Bonaventura, Paola, et al.
Publicado: (2019)

Human rhinoviruses: coming in from the cold
por: Arden, Katherine E, et al.
Publicado: (2009)

Tamoxifen: the drug that came in from the cold
por: Hughes-Davies, L, et al.
Publicado: (2009)

Challenges to addressing the unmet medical needs for immunotherapy targeting cold colorectal cancer
por: Jeong, Keun-Yeong
Publicado: (2023)

Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities
por: Jeong, Sehan, et al.
Publicado: (2023)

Oncogenic AKTivation of translation as a therapeutic target
por: Hsieh, A C, et al.
Publicado: (2011)

Gaseous metabolites as therapeutic targets in ulcerative colitis
por: Yao, Chu K, et al.
Publicado: (2023)

Advances in immunotherapy for melanoma
por: Redman, Jason M., et al.
Publicado: (2016)

Immunotherapy for pancreatic cancer
por: Yoon, Jai Hoon, et al.
Publicado: (2021)

Protective effects of combined treatment with ciprofol and mild therapeutic hypothermia during cerebral ischemia-reperfusion injury
por: Wang, Yi-Chao, et al.
Publicado: (2023)

Blowing Hot and Cold: Body Temperature and the Microbiome
por: Huus, Kelsey E., et al.
Publicado: (2021)

Coronary vasospasm: A narrative review
por: Jewulski, Jacob, et al.
Publicado: (2021)

Strategies and challenges in treatment of varicose veins and venous insufficiency
por: Gao, Rong-Ding, et al.
Publicado: (2022)

Emerging role of autophagy in colorectal cancer: Progress and prospects for clinical intervention
por: Ma, Tian-Fei, et al.
Publicado: (2023)

ARF-BP1 as a potential therapeutic target
por: Chen, D, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_qlhpj5qbe5nurro8md3d8q54dt